Chapter 29

Calista held the phone, speechless for a moment.

That afternoon, Softhart Group's stock price plummeted on news of the core R&D team's mass exodus. The team Calista had built from scratch was the lifeblood of Softhart Medicine.

With them gone, the entire R&D department became an empty shell. Seve...

Login and Continue Reading